Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

30 December 2024 : Clinical Research  

Hemorrhagic Risk in Vestibular Schwannoma Surgeries: Insights and Implications

Alper Tabanli1ABCDEFG*, Hakan Yilmaz ORCID logo2ABCEFG, Emrah Akçay ORCID logo1ABFG, Hüseyin Berk Benek ORCID logo2ACEG, Ibrahim Burak Atci ORCID logo3BDF, Mesut Mete ORCID logo4ABDE

DOI: 10.12659/MSM.946583

Med Sci Monit 2024; 30:e946583

Table 3 Reoperation details, hospital stay, and follow-up for patients with and without postoperative hemorrhage/edema.

CharacteristicValue/hemorrhage/edema Group (n=7)No hemorrhage/edema Group (n=23)P-value
Patients requiring reoperation [n, (%)]5 (16.7%)
Time to reoperation (mean days ±SD)12±4.5
Reason for reoperation
– Intratumoral hemorrhage3 (60%)
– Peritumoral edema2 (40%)
Outcomes after reoperation [n, (%) for each GOS score]
– GOS 5 (good recovery)2 (40%)
– GOS 4 (moderate disability)1 (20%)
– GOS 3 (severe disability)1 (20%)
– GOS 1 (death)1 (20%)
Median hospital stay [days (range)]29 (15–450)9 (5–47)0.01
ICU stay required [n, (%)]5 (71.4%)3 (13%)0.003
Median ICU stay (days, range)10 (3–30)5 (2–10)0.02
Patients requiring rehabilitation [n, (%)]4 (57.1%)4 (17.4%)0.04
Median follow-up time [months (range)]12 (6–24)18 (12–36)0.05
GOS – Glasgow Outcome Scale, ICU – Intensive Care Unit.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750